Screens eight biomarkers across hepatitis B, hepatitis C, HIV and four childhood immunity markers (measles, mumps, rubella, varicella), positioned as an EPP-level immunity and bloodborne virus check.
9 biomarkers as listed by Blue Horizon Medicals.
This profile measures eight biomarkers spanning hepatitis B, hepatitis C, HIV and four childhood infections: measles, mumps, rubella and varicella. These antibody and antigen markers are commonly used to assess exposure to, or immunity against, these infections. Blue Horizon positions this profile as suitable for Exposure Prone Procedures (EPP) level screening.
Among the 13 similarly sized immunity tests we track, its eight biomarkers place it in the 96th percentile for clinical depth, the highest in this data set. That breadth comes at a price: £158.25 sits around 21% above the £130.25 median for that group. Collection is by venous blood draw, at a clinic or via a home nurse visit, with results typically back within 3 days.
The overall score is driven by strong clinical depth and documentation, and a solid results and follow-up mark since a doctor reviews the results. It loses ground on value for money given the above-median price, and on collection convenience because there is no at-home finger-prick option. Blue Horizon Medicals holds a 4.2 Trustpilot rating from 395 reviews, uses UKAS ISO 15189 partner labs, and has traded since 2009.
This suits anyone who needs the widest single-test coverage in this range, spanning hepatitis B, hepatitis C, HIV and four childhood immunity markers, particularly where EPP-level documentation is needed. It is a reasonable choice when breadth matters more than price.
If you only need one or two of these marker groups, a narrower profile would likely cost less: this test runs around 21% above the £130.25 median for similarly sized immunity tests we track. It also requires a venous blood draw at a clinic or nurse visit rather than an at-home finger-prick kit.
This is a blood test collected by venous draw, either at a clinic or through a nurse home visit; there is no at-home finger-prick option. Results are typically available within 3 days, and a doctor reviews them before they reach you.
This is Blue Horizon's broadest immunity profile in our data, covering eight biomarkers across hepatitis B, hepatitis C, HIV and four childhood infections, for £158.25 with results reviewed by a doctor within 3 days. It is priced around 21% above the £130.25 median for the 13 similarly sized immunity tests we track. The trade-off for that breadth is a higher price than narrower profiles covering fewer infections.
The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.
8 biomarkers, placing it in the 96th percentile of immunity tests we track.
A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 3 days, in line with or faster than similar tests.
Results are reviewed by a doctor; the provider does not describe the report format.
Trustpilot 4.2 from 395 reviews; accredited lab (UKAS ISO 15189 partner labs); trading 17+ years.
£158.25 against a median of £130.25 for the 13 similarly sized immunity tests we track (+21%).
Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.
Highly rated for depth and priced well below the market
An 8-marker blood test covering white and red blood cells, vitamin D, B12, iron status and inflammation, for a broad check of immune-related health.
Six-marker immunity panel below the category median
A six-marker blood panel covering IgG, IgM and IgA antibodies plus total protein, albumin and globulin, for anyone investigating frequent infections or possible immune deficiency.
Combined Covid tests, discontinued from 30 Sept 2026
A combined blood test measuring both nucleocapsid antibodies, which indicate past infection, and spike protein antibodies, which indicate a vaccine or infection response.
Broad 13-marker urine panel, competitively priced
A urine analysis under the microscope plus a culture to check for bacteria, covering signs of infection, kidney health and metabolic changes. Suits monitoring urinary symptoms or investigating an abnormal result.
